IL145290A0 - Pharmaceutical compositions comprising complexes - Google Patents
Pharmaceutical compositions comprising complexesInfo
- Publication number
- IL145290A0 IL145290A0 IL14529000A IL14529000A IL145290A0 IL 145290 A0 IL145290 A0 IL 145290A0 IL 14529000 A IL14529000 A IL 14529000A IL 14529000 A IL14529000 A IL 14529000A IL 145290 A0 IL145290 A0 IL 145290A0
- Authority
- IL
- Israel
- Prior art keywords
- complexes
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12516699P | 1999-03-19 | 1999-03-19 | |
| PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL145290A0 true IL145290A0 (en) | 2002-06-30 |
Family
ID=22418482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14529000A IL145290A0 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising complexes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020049190A1 (enExample) |
| EP (1) | EP1163247A1 (enExample) |
| JP (1) | JP2004500321A (enExample) |
| KR (1) | KR20010112343A (enExample) |
| CN (1) | CN1391577A (enExample) |
| AU (1) | AU3268500A (enExample) |
| BR (1) | BR0011678A (enExample) |
| CA (1) | CA2367282A1 (enExample) |
| CZ (1) | CZ20013307A3 (enExample) |
| HU (1) | HUP0400457A2 (enExample) |
| IL (1) | IL145290A0 (enExample) |
| MX (1) | MXPA01009410A (enExample) |
| NO (1) | NO20014526L (enExample) |
| PL (1) | PL356683A1 (enExample) |
| WO (1) | WO2000056743A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ514736A (en) | 1999-04-13 | 2004-01-30 | Anormed Inc | Process for preparing amine platinum complexes |
| JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
| US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
| GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| BR0307420A (pt) | 2002-02-04 | 2004-12-21 | Werner Haas | Compostos, composições farmacêuticas e métodos para impedir e/ou tratar doença em mamìfero |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
| ES2390457T3 (es) * | 2003-08-04 | 2012-11-13 | Johnson & Johnson Consumer Companies, Inc. | Métodos para el tratamiento de enfermedades dermatológicas |
| AU2005210285B2 (en) * | 2004-02-05 | 2008-01-24 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| FR2873037B1 (fr) * | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
| US8592617B2 (en) * | 2005-12-21 | 2013-11-26 | Roche Diagnostics Operations, Inc. | Redox mediators |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| DK2032701T3 (da) | 2006-06-23 | 2014-02-10 | Alethia Biotherapeutics Inc | Polynukleotider og polypeptider, der er inddraget i cancer |
| WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| EP2123636B1 (en) | 2007-03-22 | 2012-03-21 | Kyorin Pharmaceutical Co., Ltd. | Method for producing aminoacetylpyrrolidinecarbonitrile derivative |
| CA2740900C (en) | 2008-11-03 | 2019-09-24 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
| DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| HUE045943T2 (hu) | 2011-03-31 | 2020-02-28 | Adc Therapeutics Sa | Veseasszociált antigén 1 és antigénkötõ fragmensei elleni antitestek |
| WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
| ES2628634T3 (es) | 2011-07-21 | 2017-08-03 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas |
| NZ625758A (en) | 2012-01-09 | 2016-05-27 | Alethia Biotherapeutics Inc | Method for treating breast cancer |
| DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
| DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| WO2016065435A2 (en) * | 2014-10-30 | 2016-05-06 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
| CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
| US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
| GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
| SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Ceased
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Withdrawn
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004500321A (ja) | 2004-01-08 |
| CA2367282A1 (en) | 2000-09-28 |
| EP1163247A1 (en) | 2001-12-19 |
| NO20014526L (no) | 2001-10-16 |
| WO2000056743A1 (en) | 2000-09-28 |
| CZ20013307A3 (cs) | 2002-05-15 |
| PL356683A1 (en) | 2004-06-28 |
| HUP0400457A2 (hu) | 2004-05-28 |
| MXPA01009410A (es) | 2003-06-06 |
| NO20014526D0 (no) | 2001-09-18 |
| AU3268500A (en) | 2000-10-09 |
| KR20010112343A (ko) | 2001-12-20 |
| CN1391577A (zh) | 2003-01-15 |
| US20020049190A1 (en) | 2002-04-25 |
| BR0011678A (pt) | 2002-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145290A0 (en) | Pharmaceutical compositions comprising complexes | |
| HUP0202513A3 (en) | Betha-carboline pharmaceutical compositions | |
| GB0001662D0 (en) | Pharmaceutical compositions | |
| GB0028088D0 (en) | Pharmaceutical compositions | |
| PL351387A1 (en) | Pharmaceutical composition | |
| IL147778A0 (en) | Pharmaceutical compositions containing cyclobenzaprine | |
| HUP0103507A3 (en) | Pharmaceutical compositions comprising 2-quinolones | |
| GB9923436D0 (en) | Pharmaceutical compositions | |
| HUP0201372A3 (en) | Pharmaceutical compositions comprising cyclosporin | |
| EP1166786A4 (en) | MEDICAL COMPOSITIONS | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| GB9904163D0 (en) | Pharmaceutical compositions | |
| IL148691A0 (en) | Pharmaceutical compositions containing ciclesonide | |
| GB9911017D0 (en) | Pharmaceutical compositions | |
| IL148106A0 (en) | Pharmaceutical compositions comprising 4-quinolones | |
| GB9904911D0 (en) | Pharmaceutical compositions | |
| GB9909154D0 (en) | Pharmaceutical formulation | |
| IL130325A0 (en) | Pharmaceutical compositions comprising allicin | |
| IL149470A0 (en) | Pharmaceutical compositions containing carboxamidoadenosine derivatives | |
| GB9902651D0 (en) | Pharmaceutical compositions | |
| IL147413A0 (en) | Pharmaceutical compositions comprising grf | |
| GB9926251D0 (en) | Pharmaceutical formulation | |
| GB9902591D0 (en) | Pharmaceutical compositions | |
| GB9920652D0 (en) | Pharmaceutical compositions | |
| GB9902594D0 (en) | Pharmaceutical compositions |